Objective
This research asks how pharmaceuticals prescribe the healthy subject. It examines the cultural meanings and expectations attached to four prescription drugs, and compares the policies and practices around their use in two countries, Sweden and the UK.
Empirically, it studies prescription medicines on the outer edges of adulthood: the HPV vaccine; hormone treatments for early puberty; alpha-blockers against Benign Prostrate Hyperplasia; and pharmaceutical developments against Alzheimer s disease. This view from the edges of the mature subject will bring into focus the practices and pleasures, responsibilities and rewards the adult subject position contains (or at least promises), the gendered positionalities it entails and culturally specific expectations articulated by medical prescriptions. The project conceptualizes of pharmaceuticals as flexible technologies, as actors which influence our identities but which also work within and are constrained by institutional policies, social values, medical practices and the material world.
The study will open new research horizons on two levels: The groundbreaking methodological approach, with hands-on, collaborative analytical work in PhD courses and analysis workshops between the participants and sites, will ensure an interdisciplinary approach by truly in actual research practice combining approaches from Science Technology and Society, Gender Studies and Posthumanist Studies. In addition, while firmly grounded in concepts of performative subjecthood, identity, the Self and materialities, this project will force a re-reading of the empirical material through ideas from early medical sociology texts, work which viewed health, illness and treatments as embedded in and performed by communities rather than as possessions and responsibilities of the individual patient. This collaborative re-reading will challenge theoretical ideas about the medicalization of the healthy subject and critical pharmaceutical studie
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
- medical and health sciences basic medicine neurology dementia alzheimer
- social sciences sociology gender studies
- medical and health sciences basic medicine pharmacology and pharmacy pharmaceutical drugs vaccines
- medical and health sciences health sciences infectious diseases DNA viruses
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
ERC-2010-StG_20091209
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Host institution
581 83 Linköping
Sweden
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.